1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Polyneuron Pharmaceuticals AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy PPSGG, Placebo - Anti-MAG Neuropathy | Phase 1 / Phase 2 | Terminated | Polyneuron Pharmaceuticals AG | 1 | 2020-11-17 | 2021-10-15 |
Peripheral Nervous System Diseases (1)
France (1) · Netherlands (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Hedvika Lazar (1)